FORMATION OF PGF(2)-ISOPROSTANES DURING THE OXIDATIVE MODIFICATION OF LOW-DENSITY-LIPOPROTEIN

被引:59
作者
GOPAUL, NK
NOUROOZZADEH, J
MALLET, AI
ANGGARD, EE
机构
[1] UNIV LONDON UNIV COLL,DEPT MED,DIV CLIN PHARMACOL & TOXICOL,LONDON WC1E 6JJ,ENGLAND
[2] UNITED MED & DENT SCH GUYS & ST THOMASS HOSP,ST JOHNS INST DERMATOL,LONDON SE1 7EH,ENGLAND
关键词
D O I
10.1006/bbrc.1994.1453
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
It has been recently reported that a series of prostaglandin F-2-like compounds (PGF(2) isoprostanes) are produced in vivo by non-enzymatic peroxidation of arachidonic acid. Of these, 8-epi-PGF(2 alpha) is the major component and has been shown to be a potent vasoconstrictor. Here we investigated the formation of PGF(2)-isoprostanes during copper-mediated oxidation of low density lipoprotein (LDL). Free and total (sum of free and esterified) levels of PGF(2)-isoprostanes were measured at times 0, 3, 6, 8 and 24 h, using a solid-phase extraction procedure and gas chromatography - mass spectrometry. In native LDL, free levels of PGF(2)-isoprostanes were between 0.06 and 0.10 ng/mg protein (n = 4), and the total levels ranged from 0.027 to 0.057 ng/mg protein (n = 4). Free levels of the isoprostanes were found to increase throughout the oxidation, whereas total levels reached a maximum after 3 h then gradually decreased. 8-epi-PGF(2 alpha) was the major isoprostane formed (free concentration after 24 h 1.8 F 0.1 ng/mg protein (n = 4); total concentrations of 8.8 +/- 1.8 and 6.1 +/- 3.6 ng/mg protein (n = 4) after 3 and 24 h, respectively). The levels of isoprostanes correlated well with other indices of lipid peroxidation (conjugated dienes, hydroperoxides, thiobarbituric reactive substances) measured at similar time points. The release of PGF(2)-isoprostanes from oxidised LDL in macrophages could be a contributory factor in the development of atherosclerosis. (C) 1994 Academic Press, Inc.
引用
收藏
页码:338 / 343
页数:6
相关论文
共 14 条
[1]  
BANERJEE M, 1992, IN PRESS AM J PHYSL
[2]   VITAMIN-E AND OTHER LIPOPHILIC ANTIOXIDANTS PROTECT LDL AGAINST OXIDATION [J].
ESTERBAUER, H ;
ROTHENEDER, M ;
STRIEGL, G ;
WAEG, G ;
ASHY, A ;
SATTLER, W ;
JURGENS, G .
FETT WISSENSCHAFT TECHNOLOGIE-FAT SCIENCE TECHNOLOGY, 1989, 91 (08) :316-324
[3]   BIOCHEMICAL, STRUCTURAL, AND FUNCTIONAL-PROPERTIES OF OXIDIZED LOW-DENSITY-LIPOPROTEIN [J].
ESTERBAUER, H ;
DIEBERROTHENEDER, M ;
WAEG, G ;
STRIEGL, G ;
JURGENS, G .
CHEMICAL RESEARCH IN TOXICOLOGY, 1990, 3 (02) :77-92
[4]   DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM [J].
HAVEL, RJ ;
EDER, HA ;
BRAGDON, JH .
JOURNAL OF CLINICAL INVESTIGATION, 1955, 34 (09) :1345-1353
[5]   FERROUS ION OXIDATION IN THE PRESENCE OF XYLENOL ORANGE FOR DETECTION OF LIPID HYDROPEROXIDE IN LOW-DENSITY-LIPOPROTEIN [J].
JIANG, ZY ;
HUNT, JV ;
WOLFF, SP .
ANALYTICAL BIOCHEMISTRY, 1992, 202 (02) :384-389
[6]   MODIFICATION OF HUMAN-SERUM LOW-DENSITY-LIPOPROTEIN BY OXIDATION - CHARACTERIZATION AND PATHOPHYSIOLOGICAL IMPLICATIONS [J].
JURGENS, G ;
HOFF, HF ;
CHISOLM, GM ;
ESTERBAUER, H .
CHEMISTRY AND PHYSICS OF LIPIDS, 1987, 45 (2-4) :315-336
[7]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265
[8]   NON-CYCLOOXYGENASE-DERIVED PROSTANOIDS (F2-ISOPROSTANES) ARE FORMED INSITU ON PHOSPHOLIPIDS [J].
MORROW, JD ;
AWAD, JA ;
BOSS, HJ ;
BLAIR, IA ;
ROBERTS, LJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (22) :10721-10725
[9]   A SERIES OF PROSTAGLANDIN-F2-LIKE COMPOUNDS ARE PRODUCED INVIVO IN HUMANS BY A NONCYCLOOXYGENASE, FREE RADICAL-CATALYZED MECHANISM [J].
MORROW, JD ;
HILL, KE ;
BURK, RF ;
NAMMOUR, TM ;
BADR, KF ;
ROBERTS, LJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (23) :9383-9387
[10]  
NOUROOZZADEH J, UNPUB ANAL BIOCH